Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 2091-2094

  Apeland, Terje ^a   Hartmann, Anders ^b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Focal segmental glomerulosclerosis; Kidney graft; Rituximab

Indexed keywords

ALBUMIN; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS;

ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; FOCAL GLOMERULOSCLEROSIS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; NEPHRECTOMY; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; SCHOOL CHILD;

ANTIBODIES, MONOCLONAL; CHILD; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RENAL DIALYSIS; REOPERATION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 44449100331     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn099     Document Type: Article

References (18)

1. Briggs JD, Jones E. (Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association). Recurrence of glomerulonephritis following renal transplantation. Nephrol Dial Transplant 1999; 14: 564-565
2. Ponticelli C, Campise M, Tarantino A. The different patterns of response to plasmapheresis of recurrent focal and segmental glomerulosclerosis. Transplant Proc 2002; 34: 3069-3071
3. Cheong HI, Han HW, Park HW et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000; 15: 78-81
4. Nozu K, Iijima K, Fujisawa M et al. Rituximab treatment for post-transplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 2005; 20: 1660-1663
5. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006; 354: 1961-1963
6. El-Firjani A, Hoar S, Karpinski J et al. Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy. Nephrol Dial Transplant 2007
7. Gossmann J, Scheuermann EH, Porubsky S et al. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 2007; 20: 558-562
8. Hristea D, Hadaya K, Marangon N et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007; 20: 102-105
9. Kamar N, Faguer S, Esposito L et al. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 2007; 67: 250-254
10. Marks SD, McGraw M. Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? Pediatr Nephrol 2007; 22: 158-160
11. Meyer TN, Thaiss F, Stahl RA. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 2007; 20: 1066-1071
12. Nakayama M, Kamei K, Nozu K et al. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 2008; 23: 481-485
13. Yabu JM, Ho B, Scandling JD et al. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008; 8: 222-227
14. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006; 6: 2535-2542
15. Pescovitz MD. Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant 2006; 6: 859-866
16. Tyden G, Donauer J, Wadstrom J et al. Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153-1155
17. Jois RN, Masding A, Somerville M et al. Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience. Rheumatology (Oxford) 2007; 46: 980-982
18. Omdal R, Wildhagen K, Hansen T et al. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response. Scand J Rheumatol 2005; 34: 229-232